Statera BioPharma Inc
STAB
Market Cap$50.81K
Close$
Share Statistics
| Market cap | $50,809.00 |
|---|---|
| Enterprise Value | $5.73 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.25 |
| Beta | 0.0 |
| Outstanding Shares | 72,584,254 |
| Avg 30 Day Volume | 5,853 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.0 |
|---|---|
| PEG | -0.0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.76 |
| Enterprise Value to EBIT | -0.15 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.12 |
| Debt to Equity | -0.92 |
Revenue Sources
No data
ESG Score
No data
About Statera BioPharma Inc
4 employeesStatera Biopharma is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immu...